1. Topoisomerase I Poisons and Suppressors as Anticancer Drugs
2. a) J.M. Fortune, L. Velea, D.E. Graves, T. Utsugi, Y. Yamada, N. Oshero, Biochemistry 38 (1999) 15580–15586.; b) C. Bailly, X.Qu, J. B.Chaires, P.Colson, C. Houssier, M. Ohkubo, S.Nishimura, T. Yoshinari, J. Med. Chem. 42 (1999) 2927–2935.; c) J.A.Wilson-Byl, J.M. Fortune, A. Burden, J.L. Nitiss, T. Utsugi, Y. Yamada; N. Oshero, Biochemistry 38 (1999) 15573–15579; d) H. Minderman, C. Wrzosek, S.Cao, T. Utsugi, T. Kobunai, Y. Yamada, Y. M. Rustum, Cancer Chemother. Pharmacol. 45 (2000) 78–84.
3. Photoinduced Switch of a DNA/RNA Inactive Molecule into a Classical Intercalator
4. a) P. Cagniant, D. Cagniant, in: A.R. Katritzky, A.J. Boulton, (Eds.), Advances in Heterocyclic Chemistry, vol. 18, Academic Press, New York, 1975, pp. 338.; b) E. Campaigne, in: C.W. Bird, Cheeseman (Eds.), Comprehensive Heterocyclic Chemistry, vol 4, G.W.H. Pergamon, Oxford, 1984, pp. 910; c) B.A. Keay, P.W. Dibble, in: A.R. C.W. Katritzky, Rees, E. F. V. Scriven (Eds.), Comprehensive Heterocyclic Chemistry II, vol 2, Pergamon, Oxford, 1996, pp. 395; d) R.K. Russel, in: A.R. Katritzky; C.W. Rees, E.F.V. Scriven (Eds.), Comprehensive Heterocyclic Chemistry II, vol 2, Pergamon, Oxford, 1996, pp 679; e) R.P. Haugland, in: M.T.Z. Spence (Eds.), Handbook of Fluorescent Probes and Research Chemicals, Molecular Probes, Inc. O.R. Eugene, 1996.